Search Results - "Shaker, Mohamed E."

Refine Results
  1. 1

    The contribution of sterile inflammation to the fatty liver disease and the potential therapies by Shaker, Mohamed E.

    Published in Biomedicine & pharmacotherapy (01-04-2022)
    “…Hepatic inflammation is prevalent in several metabolic liver diseases. Recent scientific advances about the pathogenesis of metabolic liver diseases showed an…”
    Get full text
    Journal Article
  2. 2

    The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice livers by Shaker, Mohamed E., Trawick, Bobby N., Mehal, Wajahat Z.

    Published in Biochemical pharmacology (15-07-2016)
    “…[Display omitted] Ischemia/reperfusion (I/R) injury constitutes a major reason for failure of liver surgeries and transplantation. I/R injury is more severe in…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Nilotinib induces apoptosis and autophagic cell death of activated hepatic stellate cells via inhibition of histone deacetylases by Shaker, Mohamed E., Ghani, Ayaz, Shiha, Gamal E., Ibrahim, Tarek M., Mehal, Wajahat Z.

    Published in Biochimica et biophysica acta (01-08-2013)
    “…Increasing hepatic stellate cell (HSC) death is a very attractive approach for limiting liver fibrosis. Tyrosine kinase inhibitors have been shown to have…”
    Get full text
    Journal Article
  9. 9

    Digoxin mitigates diethylnitrosamine-induced acute liver injury in mice via limiting production of inflammatory mediators by Shaker, Mohamed E., Hamed, Mohamed F., Shaaban, Ahmed A.

    Published in Saudi pharmaceutical journal (01-03-2022)
    “…The cardiotonic digoxin has been recently shown to possess an anti-inflammatory potential in numerous metabolic and inflammatory disorders. However, data about…”
    Get full text
    Journal Article
  10. 10

    Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib by Shaker, Mohamed E., Gomaa, Hesham A. M., Hazem, Sara H., Abdelgawad, Mohamed A., El-Mesery, Mohamed, Shaaban, Ahmed A.

    Published in Frontiers in pharmacology (07-08-2023)
    “…The sterile inflammatory response mediated by Toll-like receptors (TLRs) 4 and 9 is implicated in the massive hepatic damage caused by acetaminophen…”
    Get full text
    Journal Article
  11. 11

    Inhibition of Bruton tyrosine kinase by acalabrutinib dampens lipopolysaccharide/galactosamine-induced hepatic damage by Shaker, Mohamed E., Gomaa, Hesham A.M., Alharbi, Khalid S., Al-Sanea, Mohammad M., El-Mesery, Mohamed E., Hazem, Sara H.

    Published in Biomedicine & pharmacotherapy (01-11-2020)
    “…[Display omitted] •The effect of the BTK inhibitor acalabrutinib was tested on hepatic damage.•Acalabrutinib inhibited LPS/D-GaIN-induced hepatic injury and…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Inhibitions of monoamine oxidases by ferulic acid hydrazide derivatives: synthesis, biochemistry, and computational evaluation by Peedikayil, Arshida Thottile, Lee, Jiseong, Abdelgawad, Mohamed A., Ghoneim, Mohammed M., Shaker, Mohamed E., Selim, Samy, Kumar, Sunil, Dev, Sanal, Kim, Hoon, Mathew, Bijo

    Published in Applied biological chemistry (01-12-2023)
    “…Monoamine oxidases (MAOs) regulate neurotransmitters, and changes in their regulation lead to neurogenerative diseases (NDs). Therefore, MAO inhibitors are…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Anti-cancer perspectives of resveratrol: a comprehensive review by Anwar, Muhammad Junaid, Altaf, Areeba, Imran, Muhammad, Amir, Muhammad, Alsagaby, Suliman A., Abdulmonem, Waleed Al, Mujtaba, Ahmed, El-Ghorab, Ahmed H., Ghoneim, Mohammed M., Hussain, Muzzamal, Jbawi, Entessar Al, Shaker, Mohamed E., Abdelgawad, Mohamed A.

    Published in Food and agricultural immunology (31-12-2023)
    “…Resveratrol (RVT) is well known for its chemo-preventive and therapeutic attributes against the various kinds of cancers such as breast, prostate, pancreatic,…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Comparison of imatinib, nilotinib and silymarin in the treatment of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by Shaker, Mohamed E., Zalata, Khaled R., Mehal, Wajahat Z., Shiha, Gamal E., Ibrahim, Tarek M.

    Published in Toxicology and applied pharmacology (15-04-2011)
    “…Effective and well-tolerated anti-fibrotic drugs are currently lacking. Therefore, this study was carried out to investigate the potential anti-fibrotic…”
    Get full text
    Journal Article
  20. 20

    Piperidine: A Versatile Heterocyclic Ring for Developing Monoamine Oxidase Inhibitors by Jayan, Jayalakshmi, Chandran, Namitha, Thekkantavida, Amrutha Chandran, Abdelgawad, Mohamed A., Ghoneim, Mohammed M., Shaker, Mohamed E., Uniyal, Prerna, Benny, Feba, Zachariah, Subin Mary, Kumar, Sunil, Kim, Hoon, Mathew, Bijo

    Published in ACS omega (17-10-2023)
    “…The monoamine oxidase enzyme (MAO), which is bound on the membrane of mitochondria, catalyzes the oxidative deamination of endogenous and exogenous monoamines,…”
    Get full text
    Journal Article